8-K/A

FORM 8-K AMENDMENT

Company: Xenetic Biosciences, Inc.
Filed: May 13, 2019
Period of Report: March 1, 2019
Accession Number: 0001683168-19-001480

View Document ↗ View on SEC.gov ↗